ArticleFrontiers in allergy2025

A phase 2 randomized controlled trial using biologics to improve multi OIT outcomes (COMBINE): design, rationale, and methods.

A J Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.